Kevin D. Burris

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

Kevin D. Burris, Thaddeus F. Molski, Cen Xu et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 922 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.

Elaine Sanders‐Bush, Kevin D. Burris, Karen M. Knoth · Journal of Pharmacology and Experimental Therapeutics · 1988 · 155 citations

Medicine, Neuroscience, Pharmacology +17

Expression of the Human 5-Hydroxytryptamine1A Receptor in Sf9 Cells

Paul Butkerait, Yejia Zheng, Hazem Hallak et al. · Journal of Biological Chemistry · 1995 · 154 citations · Full text

Life Sciences, Neuroscience, Pharmacology +13

Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies

Arlene Stark, Shaun Jordan, Kelly A. Allers et al. · Psychopharmacology · 2006 · 145 citations

Medicine, Pharmacology, Pharmacotherapy +17

Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-Effect Profile

Tsuyoshi Hirose, Yasufumi Uwahodo, Sakiko Yamada et al. · Journal of Psychopharmacology · 2004 · 131 citations

Medicine, Pharmacology, Pharmacotherapy +14